Thyroid hormone modulation of rat sulphotransferase mRNA expression

Xenobiotica

Volumn 30, Issue 4, 2000, Pages 345-357

  Dunn II, R T ^a   Klaassen, C D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MESSENGER RNA; SULFOTRANSFERASE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; MALE; NONHUMAN; RAT; THYROIDECTOMY;

ANIMALIA; EUKARYOTA;

EID: 0034017175     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982500237550     Document Type: Article

References (40)

1. Barter, R. A. and Klaassen, C. D., 1992, UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. Toxicology and Applied Pharmacology, 113, 36-42.
2. Borthwick, E. B., Voice, M. W., Burchell, A. and Coughtrie, M. W., 1995, Effects of hypophysectomy and thyroxine on the expression of hepatic oestrogen, hydroxysteroid and phenol sulphotransferases. Biochemical Pharmacology, 49, 1381-1386.
3. Clissold, S. P. and Heel, R. C., 1987, Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica. Drugs, 33, 107-122.
4. DeBaun, J. R., Miller, E. C. and Miller, J. A., 1970, N-hydroxy-2-acetylaminofluorene sulphotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. Cancer Research, 30, 577-595.
5. Demyan, W. F., Sono, C. S., Kim, D. S., Her, S., Gallwitz, W., Rao, T. R., Slomczynska, M., Chatterjee, B. and Roy, A. K., 1992, Estrogen sulphotransferase of the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA. Molecular Endocrinology, 6, 589-597.
6. Fujita, K., Nagata, K., Ozawa, S., Sasano, H. and Yamazoe, Y., 1997, Molecular cloning and characterization of rat ST1B1 and human ST1B2 cDNAs, encoding thyroid hormone sulfotransferases. Journal of Biochemistry (Tokyo), 122, 1052-1061.
7. Gong, D. W., Murayama, N., Yamazoe, Y. and Kato, R., 1992, Hepatic triiodothyronine sulphation and its regulation by growth hormone and triiodothyronine in rats. Journal of Biochemistry Tokyo, 112, 112-116.
8. Goon, D. and Klaassen, C. D., 1990, Dose-dependent intestinal glucuronidation and sulphation of acetaminophen in the rat in situ. Journal of Pharmacology and Experimental Therapeutics, 252, 201-207.
9. Gregus, Z., Madhu, C. and Klaassen, C. D., 1988, Species variation in toxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. Journal of Pharmacology and Experimental Therapeutics, 244, 91-99.
10. Hellriegel, E. T., Matwyshyn, G. A., Fei, P., Dragnev, K. H., Nims, R. W., Lubet, R. A. and Kong, A. N., 1996, Regulation of gene expression of various phase I and phase II drug-metabolizing enzymes by tamoxifen in rat liver. Biochemical Pharmacology, 52, 1561-1568.
11. Jones, P. M., Burrin, J. M., Ghatei, M. A., O'Halloran, D. J., Legon, S., and Bloom, S. R., 1990, The influence of thyroid hormone status on the hypothalamo-hypophyseal growth hormone axis. Endocrinology, 126, 1374-1379.
12. Kato, R. and Yamazoe, Y., 1992, Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicology Letters, 64-65, 661-667.
13. Levy, A., Matovelle, M. C., Lightman, S. L. and Young, W. S., 1992, The effects of pituitary stalk transection, hypophysectomy and thyroid hormone status on insulin-like growth factor 2-, growth hormone releasing hormone, and somatostatin mRNA prevalence in rat brain. Brain Research, 579, 1-7.
14. Liu, L. and Klaassen, C. D., 1996a, Different mechanism of saturation of acetaminophen sulphate conjugation in mice and rats. Toxicology and Applied Pharmacology, 139, 128-134.
15. Liu, L. and Klaassen, C. D., 1996b, Ontogeny and hormonal basis of male-dominant rat hepatic sulphotransferases. Molecular Pharmacology, 50, 565-572.
16. Liu, L. and Klaassen, C. D., 1996c, Ontogeny and hormonal basis of female-dominant rat hepatic sulphotransferases. Journal of Pharmacology and Experimental Therapeutics, 279, 386-391.
17. Liu, L. and Klaassen, C. D., 1996d, Regulation of hepatic sulphotransferases by steroidal chemicals in rats. Drug Metabolism and Disposition, 24, 854-858.
18. Meerman, J. H. N. and Vandepoll, M. L. M., 1994, Metabolic activation routes of arylamines and their genotoxic effects. Environmental Health Perspectives, 102, 153-159.
19. Mulder, G. J., Jakoby, W. B. and Mulder, G. J. (eds), 1990, Sulphation. In Conjugation Reactions in Drug Metabolism (London: Taylor & Francis), pp. 107-161.
20. Murayama, N., Shimada, M., Yamazoe, Y. and Kato, R., 1991, Difference in the susceptibility of two phenobarbital-inducible forms, P450IIB1 and P450IIB2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450IIB2 suppression by thyroid hormone acting directly, but not through the pituitary system. Molecular Pharmacology, 39, 811-817.
21. Nagata, K., Ozawa, S., Miyata, M., Shimada, M., Gong, D. W., Yamazoe, Y. and Kato, R., 1993, Isolation and expression of a cDNA encoding a male-specific rat sulphotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. Journal of Biological Chemistry, 268, 24720-24725.
22. Nuwaysir, E. F., Daggett, D. A., Jordan, V. C. and Pitot, H. C., 1996, Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen. Cancer Research, 56, 3704-3710.
23. Ogura, K., Kajita, J., Narihata, H., Watabe, T., Ozawa, S., Nagata, K., Yamazoe, Y. and Kato, R., 1989, Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulphotransferase. Biochemical and Biophysical Research Communication, 165, 168-174.
24. Ogura, K., Kajita, J., Narihata, H., Watabe, T., Ozawa, S., Nagata, K., Yamazoe, Y. and Kato, R., 1990, cDNA cloning of the hydroxysteroid sulphotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochemical Biophysical Research Communications, 166, 1494-1500.
25. Ozawa, S., Nagata, K., Gong, D., Yamazoe, Y. and Kato, R., 1990, Nucleotide sequence of a full-length cDNA (PST-1) for aryl sulphotransferase from rat liver. Nucleic Acids Research, 18, 4001.
26. Ram, P. A. and Waxman, D. J., 1991, Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Molecular Endocrinology, 5, 13-20.
27. Runge-Morris, M., Rose, K. and Kocarek, T. A., 1996, Regulation of rat hepatic sulphotransferase gene expression by glucocorticoid hormones. Drug Metabolism and Disposition, 24, 1095-1101.
28. Runge-Morris, M. and Wilusz, J., 1994, Suppression of hydroxysteroid sulphotransferase-a gene expression by 3-methylcholanthrene. Toxicology and Applied Pharmacology, 125, 133-141.
29. Sakakibara, Y., Takami, Y., Zwieb, C., Nakayama, T., Suiko, M., Nakajima, H. and Liu, M. C., 1995, Purification, characterization, and molecular cloning of a novel rat liver Dopa/tyrosine sulphotransferase. Journal of Biological Chemistry, 270, 30470-30478.
30. Singleton, D. W., Lei, X. D., Webb, S. J., Prough, R. A. and Geoghegan, T. E., 1999, Cytochrome P-450 mRNAs are modulated by dehydroepiandrosterone, nafenopin, and triiodothyronine. Drug Metabolism and Disposition, 27, 193-200.
31. Skett, P. and Weir, A., 1983, Sex- and substrate-dependent effects of the thyroid gland on drug metabolism in the rat. Biochemical Pharmacology, 32, 3115-3117.
32. Surh, Y. J., Lai, C. C., Miller, J. A. and Miller, E. C., 1987, Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12-methylbenz[a]anthracene and its electrophilic sulphuric acid ester metabolite in preweanling rats and mice. Biochemical and Biophysical Research Communications, 144, 576-582.
33. Thomas, R. C. and Harpootlian, H., 1975, Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeys. Journal of Pharmacological Science, 64, 1366-1371.
34. Ueda, R., Shimada, M., Hashimoto, H., Ishikawa, H. and Yamazoe, Y., 1997, Distinct regulation of two hydroxysteroid sulphotransferases, ST2A1 and ST2A2, by growth hormone: a unique type of growth hormone regulation in rats. Journal of Pharmacology and Experimental Therapeutics, 282, 1117-1121.
35. Visser, T. J., 1994, Role of sulphation in thyroid hormone metabolism. Chemico and Biological Interactions, 92, 293-303.
36. Watabe, T., Ogura, K., Satsukawa, M., Okuda, H. and Hiratsuka, A., 1994, Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chemico and Biological Interactions, 92, 87-105.
37. Webe, S. J., Xiao, G. H., Geoghegan, T. E. and Prough, R. A., 1996, Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Molecular Pharmacology, 49, 276-287.
38. Yamazoe, Y., Manabe, S., Murayama, N. and Kato, R., 1987, Regulation of hepatic sulfotransferase catalyzing the activation of N-hydroxyarylamide and N-hydroxyarylamine by growth hormone. Molecular Pharmacology, 32, 536-541.
39. Yamazoe, Y., Gong, D., Murayama, N., Abu-Zeid, M. and Kato, R., 1989, Regulation of hepatic cortisol sulfotransferase in rats by pituitary growth hormone. Molecular Pharmacology, 35, 707-712.
40. Yamazoe, Y., Manabe, S., Murayama, N. and Kato, R., 1997, Regulation of hepatic sulphotransferase catalyzing the activation of N-hydroxylamide and N-hydroxylarylamine by growth hormone. Molecular Pharmacology, 32, 536-541.